A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the safety,
tolerability, pharmacokinetics (the exposure of the trial drug in the body) and
pharmacodynamics (the effect of the investigated drug on the body) of insulin 320 in healthy
subjects.